Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels.

Standard

Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels. / Kühlcke, Klaus; Fehse, Boris; Schilz, Andrea; Loges, Sonja; Lindemann, Carsten; Ayuketang Ayuk, Francis; Lehmann, Friederike; Stute, Norbert; Fauser, Axel A; Zander, Axel R; Eckert, Hans-Georg.

in: MOL THER, Jahrgang 5, Nr. 4, 4, 2002, S. 473-478.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Kühlcke, K, Fehse, B, Schilz, A, Loges, S, Lindemann, C, Ayuketang Ayuk, F, Lehmann, F, Stute, N, Fauser, AA, Zander, AR & Eckert, H-G 2002, 'Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels.', MOL THER, Jg. 5, Nr. 4, 4, S. 473-478. <http://www.ncbi.nlm.nih.gov/pubmed/11945075?dopt=Citation>

APA

Kühlcke, K., Fehse, B., Schilz, A., Loges, S., Lindemann, C., Ayuketang Ayuk, F., Lehmann, F., Stute, N., Fauser, A. A., Zander, A. R., & Eckert, H-G. (2002). Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels. MOL THER, 5(4), 473-478. [4]. http://www.ncbi.nlm.nih.gov/pubmed/11945075?dopt=Citation

Vancouver

Bibtex

@article{9f67296940214f1e9888fb374bf26121,
title = "Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels.",
abstract = "Efficient retroviral gene transfer into primary cells is a prerequisite for various gene therapeutic strategies. We have developed a transduction protocol based on the preloading of tissue culture vessels with retroviral particles by low-speed (1000g) centrifugation. We show that vector-preloaded tissue culture vessels allow highly efficient gene transfer into various target cells. We obtained transduction rates of up to 85% for primary T lymphocytes after just a single round of transduction. Under clinically relevant conditions using a vector developed for suicide gene therapy and produced under good manufacturing practice (GMP) conditions, the described method allowed generation of large numbers (>2x10(9)) of gene-modified T cells. The preloading concept ensures transduction of target cells in their optimal growth medium regardless of the medium used for vector production. This facilitated highly efficient gene transfer into quite different target cells such as CD34(+) and AC133(+) bone marrow progenitor as well as mesenchymal stem cells. The presented method combines high gene-transfer rates with a great potential for standardization in accordance with GMP guidelines and is consequently well suited for both research and clinical applications. (c)2002 Elsevier Science (USA).",
author = "Klaus K{\"u}hlcke and Boris Fehse and Andrea Schilz and Sonja Loges and Carsten Lindemann and {Ayuketang Ayuk}, Francis and Friederike Lehmann and Norbert Stute and Fauser, {Axel A} and Zander, {Axel R} and Hans-Georg Eckert",
year = "2002",
language = "Deutsch",
volume = "5",
pages = "473--478",
journal = "MOL THER",
issn = "1525-0016",
publisher = "NATURE PUBLISHING GROUP",
number = "4",

}

RIS

TY - JOUR

T1 - Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels.

AU - Kühlcke, Klaus

AU - Fehse, Boris

AU - Schilz, Andrea

AU - Loges, Sonja

AU - Lindemann, Carsten

AU - Ayuketang Ayuk, Francis

AU - Lehmann, Friederike

AU - Stute, Norbert

AU - Fauser, Axel A

AU - Zander, Axel R

AU - Eckert, Hans-Georg

PY - 2002

Y1 - 2002

N2 - Efficient retroviral gene transfer into primary cells is a prerequisite for various gene therapeutic strategies. We have developed a transduction protocol based on the preloading of tissue culture vessels with retroviral particles by low-speed (1000g) centrifugation. We show that vector-preloaded tissue culture vessels allow highly efficient gene transfer into various target cells. We obtained transduction rates of up to 85% for primary T lymphocytes after just a single round of transduction. Under clinically relevant conditions using a vector developed for suicide gene therapy and produced under good manufacturing practice (GMP) conditions, the described method allowed generation of large numbers (>2x10(9)) of gene-modified T cells. The preloading concept ensures transduction of target cells in their optimal growth medium regardless of the medium used for vector production. This facilitated highly efficient gene transfer into quite different target cells such as CD34(+) and AC133(+) bone marrow progenitor as well as mesenchymal stem cells. The presented method combines high gene-transfer rates with a great potential for standardization in accordance with GMP guidelines and is consequently well suited for both research and clinical applications. (c)2002 Elsevier Science (USA).

AB - Efficient retroviral gene transfer into primary cells is a prerequisite for various gene therapeutic strategies. We have developed a transduction protocol based on the preloading of tissue culture vessels with retroviral particles by low-speed (1000g) centrifugation. We show that vector-preloaded tissue culture vessels allow highly efficient gene transfer into various target cells. We obtained transduction rates of up to 85% for primary T lymphocytes after just a single round of transduction. Under clinically relevant conditions using a vector developed for suicide gene therapy and produced under good manufacturing practice (GMP) conditions, the described method allowed generation of large numbers (>2x10(9)) of gene-modified T cells. The preloading concept ensures transduction of target cells in their optimal growth medium regardless of the medium used for vector production. This facilitated highly efficient gene transfer into quite different target cells such as CD34(+) and AC133(+) bone marrow progenitor as well as mesenchymal stem cells. The presented method combines high gene-transfer rates with a great potential for standardization in accordance with GMP guidelines and is consequently well suited for both research and clinical applications. (c)2002 Elsevier Science (USA).

M3 - SCORING: Zeitschriftenaufsatz

VL - 5

SP - 473

EP - 478

JO - MOL THER

JF - MOL THER

SN - 1525-0016

IS - 4

M1 - 4

ER -